Christian Waage — SEC insider filings

SEC reporting owner CIK 1553179. 29 insider filings on record with FilingPulse; latest filed 2026-08-26.

Transaction summary — filings shown

Covers all 29 filings on record, filed 2020-10-14 to 2026-08-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Gossamer Bio, Inc. (GOSS)EVP, Tech Ops and Admin183 legs · 27,934 sh · $95,9573 legs · 22,642 sh · $155,06742
HERON THERAPEUTICS, INC. /DE/ (HRTX)Director11—4 legs · 1,200 sh · $16,42514

Insider filings — Christian Waage

FiledFormIssuerReported transactionsSource
2026-08-264Gossamer Bio, Inc. (GOSS)Grant/award (A): 2,900,026 (derivative) @ $0EDGAR
2026-03-204Gossamer Bio, Inc. (GOSS)Disposition to issuer (D): 506,250 (derivative) · Disposition to issuer (D): 440,000 (derivative) · Disposition to issuer (D): 375,000 (derivative) · Disposition to issuer (D): 125,000 (derivative) · Disposition to issuer (D): 157,500 (derivative) · Disposition to issuer (D): 157,500 (derivative) · +14 moreEDGAR
2026-02-034HERON THERAPEUTICS, INC. /DE/ (HRTX)Grant/award (A): 53,960 @ $0EDGAR
2026-01-054Gossamer Bio, Inc. (GOSS)Grant/award (A): 84,500 @ $0 · Grant/award (A): 506,250 (derivative) @ $0EDGAR
2025-10-024Gossamer Bio, Inc. (GOSS)Grant/award (A): 125,000 @ $0EDGAR
2025-03-064Gossamer Bio, Inc. (GOSS)Grant/award (A): 440,000 (derivative) @ $0EDGAR
2025-02-044/AHERON THERAPEUTICS, INC. /DE/ (HRTX)Grant/award (A): 17,950 @ $0 · Grant/award (A): 35,900 (derivative) @ $0EDGAR
2025-02-034HERON THERAPEUTICS, INC. /DE/ (HRTX)Grant/award (A): 17,950 @ $0 · Grant/award (A): 35,900 (derivative) @ $1.73EDGAR
2024-03-284Gossamer Bio, Inc. (GOSS)Sale (S): 6,430 @ $1.16EDGAR
2024-01-194HERON THERAPEUTICS, INC. /DE/ (HRTX)Grant/award (A): 13,948 @ $0 · Grant/award (A): 83,685 (derivative) @ $0EDGAR
2024-01-044Gossamer Bio, Inc. (GOSS)Grant/award (A): 375,000 (derivative) @ $0EDGAR
2023-11-224Gossamer Bio, Inc. (GOSS)Grant/award (A): 125,000 (derivative) @ $0EDGAR
2023-07-264Gossamer Bio, Inc. (GOSS)Grant/award (A): 13,504 @ $1.82 · Grant/award (A): 3,376 (derivative) @ $0.12EDGAR
2023-05-094Gossamer Bio, Inc. (GOSS)Disposition to issuer (D): 105,000 (derivative) · Disposition to issuer (D): 71,500 (derivative) · Disposition to issuer (D): 90,000 (derivative) · Disposition to issuer (D): 190,000 (derivative) · Grant/award (A): 70,000 (derivative) · Grant/award (A): 47,667 (derivative) · +2 moreEDGAR
2023-03-224Gossamer Bio, Inc. (GOSS)Purchase (P): 18,500 @ $1.20 · Grant/award (A): 157,500 (derivative) @ $0EDGAR
2022-12-204HERON THERAPEUTICS, INC. /DE/ (HRTX)Grant/award (A): 38,580 @ $0 · Grant/award (A): 77,160 (derivative) @ $0EDGAR
2022-12-094Gossamer Bio, Inc. (GOSS)Grant/award (A): 157,500 (derivative) @ $0EDGAR
2022-07-154Gossamer Bio, Inc. (GOSS)Purchase (P): 6,934 @ $7.21EDGAR
2022-03-244Gossamer Bio, Inc. (GOSS)Sale (S): 10,722 @ $8.91EDGAR
2022-01-104Gossamer Bio, Inc. (GOSS)Grant/award (A): 190,000 (derivative) @ $0EDGAR
2021-12-234HERON THERAPEUTICS, INC. /DE/ (HRTX)Sale (S): 300 @ $9.73 · Grant/award (A): 10,452 @ $0 · Grant/award (A): 20,903 (derivative) @ $0EDGAR
2021-09-234HERON THERAPEUTICS, INC. /DE/ (HRTX)Sale (S): 300 @ $12.31EDGAR
2021-06-224HERON THERAPEUTICS, INC. /DE/ (HRTX)Sale (S): 300 @ $15.20EDGAR
2021-04-164HERON THERAPEUTICS, INC. /DE/ (HRTX)Sale (S): 300 @ $17.51EDGAR
2021-03-254Gossamer Bio, Inc. (GOSS)Sale (S): 5,490 @ $9.48EDGAR
2021-03-014Gossamer Bio, Inc. (GOSS)Grant/award (A): 45,000 @ $0 · Grant/award (A): 90,000 (derivative) @ $0EDGAR
2020-12-234HERON THERAPEUTICS, INC. /DE/ (HRTX)Grant/award (A): 3,000 @ $0 · Grant/award (A): 18,000 (derivative) @ $0EDGAR
2020-10-154HERON THERAPEUTICS, INC. /DE/ (HRTX)Grant/award (A): 437 (derivative) @ $0EDGAR
2020-10-144Gossamer Bio, Inc. (GOSS)Purchase (P): 2,500 @ $9.53EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-13 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1553179 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs